Home
News

News

All News
By Year:
2019
2018
2017
2016

Oct 31, 2017

DiaMedica Announces Dr. Robert Stanton as Scientific Advisor for Upcoming Chronic Kidney Disease Trials

Oct 27, 2017

DiaMedica Therapeutics Announces the Early Exercise of Warrants from Strategic Investor

Sep 11, 2017

DiaMedica Announces the Initiation of Phase 2 Trial Evaluating DM199 (Recombinant Human KLK1) in Patients with Acute Ischemic Stroke

May 1, 2017

DiaMedica Announces Recently Granted Formulation Patent in U.S. for DM199

Apr 25, 2017

DiaMedica Announces Dr. Nancy Chang to its Strategic Advisory Board

Apr 18, 2017

DiaMedica Therapeutics Completes Private Placement With U.S. Based Family Office

Mar 20, 2017

DiaMedica Announces Issuance of European Composition of Matter Patent and Additional Worldwide Filings for DM199

Mar 13, 2017

DiaMedica Presents Updated Positive DM199 Phase Ib Trial Identifying A Superior Subcutaneous Delivery Profile

Dec 23, 2016

DiaMedica Announces Name Change to DiaMedica Therapeutics Inc.

Dec 20, 2016

DiaMedica Announces Positive Top-Line Results from DM199 Bridging Clinical Trial